About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Fox Chase Cancer Center
2022 Management of Early Stage Non-Small Cell Lung Cancer
2022 Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer
19th Annual Highlights of the 2020 San Antonio Breast Cancer Symposium
Genitourinary Malignancies in the Time of COVID-19
Videos
2019 Updates in Bladder and Kidney Cancer
Bladder
Kidney
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted Therapy Efficacy Data for RET & MET Mutations
By
3rd Annual Atlanta Precision Oncology Symposium
FEATURING
Hossein Borghaei
By
3rd Annual Atlanta Precision Oncology Symposium
FEATURING
Hossein Borghaei
529 views
March 7, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:59
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Featured Video
21:17
Janssen Oncology
The Man Cave
Feat.
J. Hamilton,
M. Fabrizio,
M. Taha
Videos
04:25
Total Health
LS-SCLC Updates - 2023 ASCO® Direct Philadelphia
Feat.
J. Bauman
04:35
Total Health
Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…
Feat.
J. Bauman
26:42
Total Health
ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…
Feat.
J. Bauman
06:11
Insights from 2023 EHA® Annual Meeting
EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-U…
Feat.
A. Varshavsky-Yanovsky
21:34
2023 Texas Lung Cancer Conference Coverage
The Evolving Role of Dual Checkpoint Inhibition in Advanced NSCLC
Feat.
H. Borghaei
03:05
ASCO GU 2023 Conference Coverage
ASCO GU 2023 Adjuvant Therapies in Renal Cell Carcinoma: Are New Dat…
Feat.
M. Zibelman
13:51
Fox Chase Cancer Center
Adjuvant Treatment of NSCLC: ADAURA in Context
Feat.
M. Edelman
09:51
Fox Chase Cancer Center
Influence of 1L Chemo on Survival Outcomes of Patients with Advanced…
Feat.
B. Miron
08:35
Fox Chase Cancer Center
2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…
Feat.
N. Vijayvergia
19:53
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist
2021 Update on Advanced Urothelial Cancer: Navigating 1L and Beyond …
Feat.
E. Plimack
12:36
3rd Annual Atlanta Precision Oncology Symposium
Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…
Feat.
H. Borghaei
13:52
3rd Annual Atlanta Precision Oncology Symposium
Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…
Feat.
H. Borghaei
34:34
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Immunology & IO in Lynch Syndrome: Immune System, MSI & Here…
Feat.
M. J. Hall
16:08
Fox Chase Cancer Center
Genomic Differentiation of Early-Onset CRC: When Should the Screenin…
Feat.
J. Meyer
08:15
2020 ASCO Virtual Direct™ Highlights
2020 Update on Radiation Therapy in Lung Cancer: Is High-Dose Twice-…
Feat.
H. Borghaei
10:59
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Targeted Therapy in NSCLC: Is Adjuvant Osimertin…
Feat.
H. Borghaei
03:24
Fox Chase Cancer Center
2020 ASCO Update on Advanced RCC: Pembrolizumab + Axitinib vs. Sunit…
Feat.
E. Plimack
14:38
CancerGRACE
The Role of IO in Bladder Cancer: Potential Benefits in Neoadjuvant …
Feat.
E. Plimack,
R. Sedhom
10:57
23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting
GI Cancer Risks Associated with Pathogenic Variants (PV) in the Atax…
Feat.
M. Hall
19:10
Fox Chase Updates in Bladder and Kidney Cancer 2019
2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: …
Feat.
E. Plimack
14:23
Fox Chase Cancer Center
Front Line Therapy in NSCLC: Immunotherapy vs Immunotherapy + Chemo?
Feat.
H. Borghaei
20:36
Fox Chase Cancer Center
I-O/Chemo Combination Therapies in NSCLC
Feat.
H. Borghaei
09:14
Fox Chase Cancer Center
Second Line Treatment Options in NSCLC
Feat.
H. Borghaei